Prevalence and risk factors for spasticity after stroke: a systematic review and meta-analysis

H Zeng, J Chen, Y Guo, S Tan - Frontiers in neurology, 2021 - frontiersin.org
Background: Spasticity is a common sequela of stroke. The incidence of poststroke spasticity
(PSS) has not been systematically reviewed in recent years, and some risk factors remain …

The neurophysiology of deforming spastic paresis: a revised taxonomy

M Baude, JB Nielsen, JM Gracies - Annals of physical and rehabilitation …, 2019 - Elsevier
This paper revisits the taxonomy of the neurophysiological consequences of a persistent
impairment of motor command execution in the classic environment of sensorimotor …

Spastic dystonia in stroke subjects: prevalence and features of the neglected phenomenon of the upper motor neuron syndrome

C Trompetto, A Currà, L Puce, L Mori, C Serrati… - Clinical …, 2019 - Elsevier
Objective Spastic dystonia is one of the positive phenomena of the upper motor neuron
syndrome (UMNS). It is characterised by the inability to relax a muscle leading to a …

Left-right side-specific endocrine signaling complements neural pathways to mediate acute asymmetric effects of brain injury

N Lukoyanov, H Watanabe, LS Carvalho… - Elife, 2021 - elifesciences.org
Brain injuries can interrupt descending neural pathways that convey motor commands from
the cortex to spinal motoneurons. Here, we demonstrate that a unilateral injury of the …

Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update

D Fehlings, B Agnew, H Gimeno… - … Medicine & Child …, 2024 - Wiley Online Library
Dystonia, typically characterized by slow repetitive involuntary movements, stiff abnormal
postures, and hypertonia, is common among individuals with cerebral palsy (CP). Dystonia …

Increasing the passive range of joint motion in stroke patients using botulinum toxin: the role of pain relief

C Trompetto, L Marinelli, L Mori, N Bragazzi, G Maggi… - Toxins, 2023 - mdpi.com
By blocking the release of neurotransmitters, botulinum toxin A (BoNT-A) is an effective
treatment for muscle over-activity and pain in stroke patients. BoNT-A has also been …

Spasticity in adults with cerebral palsy and multiple sclerosis measured by objective clinically applicable technique

T Yamaguchi, TH Petersen, H Kirk, C Forman… - Clinical …, 2018 - Elsevier
Objective The present study evaluated ankle stiffness in adults with and without neurological
disorders and investigated the accuracy and reproducibility of a clinically applicable method …

Spastic movement disorder: should we forget hyperexcitable stretch reflexes and start talking about inappropriate prediction of sensory consequences of movement?

JB Nielsen, MS Christensen, SF Farmer… - Experimental Brain …, 2020 - Springer
Spastic movement disorder is characterized by reduced ability to selectively activate
muscles with significant co-activation of antagonist muscles. It has traditionally been thought …

Effectiveness of Botulinum Toxin on Pain in Stroke Patients Suffering from Upper Limb Spastic Dystonia

C Trompetto, L Marinelli, L Mori, L Puce, C Avanti… - Toxins, 2022 - mdpi.com
This observational study aimed at investigating pain in stroke patients with upper limb
spastic dystonia. Forty-one consecutive patients were enrolled. A 0–10 numeric rating scale …

Do muscle changes contribute to the neurological disorder in spastic paresis?

M Pradines, M Ghédira, B Bignami, J Vielotte… - Frontiers in …, 2022 - frontiersin.org
Background At the onset of stroke-induced hemiparesis, muscle tissue is normal and
motoneurones are not overactive. Muscle contracture and motoneuronal overactivity then …